Division of Allergic Diseases, Mayo Clinic, Rochester, MN, 55905, USA.
Clin Rev Allergy Immunol. 2022 Jun;62(3):383-399. doi: 10.1007/s12016-021-08874-1. Epub 2021 Jul 10.
Perioperative anaphylaxis (PA) is a rare but life-threatening condition that poses diagnostic and management challenges in the operating room. The incidence of severe perioperative reactions is estimated to be approximately 1:7000-10,000. Management involves both immediate stabilization of the patient and identifying the culprit agent. Identification is essential to prevent recurrence of the event in subsequent surgeries and to avoid unnecessary labeling of drug allergy. Identifying all possible exposures including medications, disinfectants, latex, and dyes and choosing the appropriate tests are essential for proper evaluation. To identify the culprit, primary testing modalities include tryptase at the time of the reaction with subsequent levels and skin testing with nonirritating concentrations to the medications and substances utilized during the procedure and those potentially used as alternates. This strategy provides guidance for future surgeries and procedures. Close collaboration between the allergy, anesthesiology, and surgery teams is essential for appropriate management of these patients at the time of the reaction, during the post event evaluation and in preparation for subsequent surgeries.
围手术期过敏反应 (PA) 是一种罕见但危及生命的疾病,在手术室中存在诊断和管理方面的挑战。严重围手术期反应的发生率估计约为 1:7000-10,000。治疗涉及患者的即刻稳定和确定致敏原。确定致敏原对于防止后续手术中再次发生该事件以及避免不必要的药物过敏标记至关重要。确定所有可能的暴露,包括药物、消毒剂、乳胶和染料,并选择适当的测试,对于正确评估至关重要。为了确定致敏原,主要的检测方法包括在反应时检测类胰蛋白酶,随后进行非刺激性浓度的皮肤测试,以检测手术过程中使用的药物和物质以及潜在的替代药物。这种策略为未来的手术和程序提供了指导。在发生反应时、在事件后评估期间以及在为后续手术做准备时,过敏症、麻醉科和外科团队之间的密切合作对于这些患者的适当管理至关重要。